Extended-Spectrum
β-Lactamase (ESBL) Genotypes among Multidrug-Resistant Uropathogenic Escherichia
coli from Clinical Isolates
Saran Kumar S. and Lali Growther
Res. J. Biotech.; Vol. 20(12); 221-227;
doi: https://doi.org/10.25303/2012rjbt2210227; (2025)
Abstract
Urinary tract infections (UTIs) are a major public health concern with Escherichia
coli being the predominant uropathogen. The increasing emergence of multidrug-resistant
(MDR) strains, particularly those producing extended-spectrum β-lactamases (ESBLs),
complicates treatment strategies. This study aimed to detect and characterize ESBL
genotypes among MDR uropathogenic E. coli isolated from clinical urine samples.
Phenotypic confirmation of ESBL production was performed using standard disc diffusion
methods. Molecular analysis was conducted to identify the presence of key ESBL genes
including blaTEM, blaSHV and blaCTX-M.
A high prevalence of ESBL producers was observed with blaCTX-M being
the most common genotype detected. The isolates exhibited resistance to multiple
antibiotic classes, while showing susceptibility to carbapenems. The findings highlight
the urgent need for molecular surveillance and antibiotic stewardship to curb the
spread of ESBL-producing uropathogens in clinical settings.